Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Athena Diagnostics United States | 40 | 24 |
|
HSP, Supplemental Dominant Evaluation Athena Diagnostics United States | 12 | 6 |
|
Hereditary spastic paraplegia (HSP), autosomal dominant and X-linked Panel CeGaT GmbH Germany | 22 | 17 |
|
Asper Biogene Asper Biogene LLC Estonia | 39 | 38 |
|
CeGaT GmbH Germany | 4 | 1 |
|
Spinal Muscular Atrophy (SMA) Panel CeGaT GmbH Germany | 44 | 27 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
Fulgent Genetics United States | 4 | 1 |
|
Charcot Marie Tooth Disease Extended NGS Panel Fulgent Genetics United States | 172 | 59 |
|
Distal Hereditary Motor Neuropathy NGS Panel Fulgent Genetics United States | 38 | 15 |
|
Congenital Generalized Lipodystrophy Type 1/2 NGS Panel Fulgent Genetics United States | 5 | 2 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Fulgent Genetics United States | 53 | 27 |
|
Fulgent Genetics United States | 259 | 112 |
|
Fulgent Genetics United States | 27 | 10 |
|
Hereditary Neuropathies NGS Panel Fulgent Genetics United States | 91 | 38 |
|
Berardinelli-Seip Congenital Lipodystrophy Type 2 MGZ Medical Genetics Center Germany | 2 | 1 |
|
BSCL2-Related Neurologic Disorders/Seipinopathy MGZ Medical Genetics Center Germany | 3 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.